Necrotic Enteritis in Poultry: Etiology, Diagnosis, and Management

By Dr. Zubair Khalid, DVM, MS, PhD ·

Necrotic Enteritis in Poultry: Etiology, Diagnosis, and Management

Key Takeaways

  • Necrotic Enteritis (NE) in poultry is primarily caused by Clostridium perfringens, with NetB toxin being a critical virulence factor, leading to significant economic losses globally.
  • Predisposing factors such as coccidiosis, high-protein diets, diets high in non-starch polysaccharides, and stressors like high stocking density are crucial for disease development, allowing C. perfringens overgrowth.
  • Diagnosis relies on characteristic gross lesions (pseudomembrane, friable intestine), histopathology showing coagulative necrosis, and laboratory confirmation via culture, PCR for virulence genes (netB, cpa), or rapid immunological tests for alpha-toxin.
  • The removal of antibiotic growth promoters has led to increased NE incidence, necessitating a shift towards non-antibiotic alternatives including probiotics, prebiotics, organic acids, essential oils, and bacteriophages.
  • Effective control strategies integrate vaccination targeting NetB and CPA, rigorous coccidiosis control programs, optimized nutritional management, dry litter, and strict biosecurity protocols.

What is Necrotic Enteritis?

Necrotic enteritis (NE) is a significant enteric disease of commercial poultry, primarily broiler chickens, caused by the Gram-positive, anaerobic, spore-forming bacterium Clostridium perfringens [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease manifests in two distinct forms: an acute clinical form characterized by sudden mortality and severe intestinal necrosis, and a subclinical (chronic) form that results in reduced feed intake, impaired weight gain, and a higher feed conversion ratio (FCR) without overt mortality [<a href="#ref-2">2</a>]. The subclinical form is often considered the most economically damaging due to its insidious impact on flock performance [<a href="#ref-2">2</a>]. Global annual losses attributable to NE have been estimated at approximately USD 6 billion [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. The disease is a complex, multifactorial condition, and its pathogenesis is intricately linked to predisposing factors that disrupt the intestinal microenvironment, allowing for the overgrowth of toxigenic C. perfringens strains [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>].

Etiology and Pathogenesis

The Causal Agent: Clostridium perfringens

Clostridium perfringens is a ubiquitous bacterium found in soil, dust, sewage, and the gastrointestinal tract of healthy animals and humans [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. It is classified into different toxinotypes (A through G) based on the production of major toxins (alpha, beta, epsilon, iota, and NetB) [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. For decades, C. perfringens type A, producing alpha-toxin (CPA), was considered the primary cause of NE [<a href="#ref-9">9</a>]. However, the discovery of the NetB toxin (a pore-forming toxin) redefined the understanding of NE pathogenesis, and strains producing NetB are now classified as type G [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. While CPA is a phospholipase C that contributes to tissue damage, NetB is now recognized as the critical virulence factor required for the development of NE in poultry [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. The production of these toxins is essential for the characteristic necrosis of the intestinal mucosa [<a href="#ref-9">9</a>].

Virulence Factors and Host-Pathogen Interactions

Beyond toxin production, several other virulence factors contribute to the pathogenesis of NE. C. perfringens produces a sortase-dependent pilus, a hair-like structure on the bacterial surface that mediates adherence to collagen types I, II, and IV in the damaged intestinal tissue [<a href="#ref-11">11</a>]. This adhesive pilus, encoded by the VR-10B chromosomal locus, is critical for colonization and subsequent disease development [<a href="#ref-11">11</a>]. The pilus components, including FimA and FimB, have been shown to be essential for virulence in in vivo chicken challenge models [<a href="#ref-11">11</a>]. Other virulence-associated factors include hyaluronidases and sialidases, which facilitate tissue degradation and nutrient acquisition [<a href="#ref-8">8</a>]. The Agr-like quorum sensing (QS) system also plays a crucial role in regulating the expression of these virulence factors, including NetB and the pilus, and is required for full pathogenesis [<a href="#ref-12">12</a>].

Predisposing Factors

NE is a multifactorial disease, and the mere presence of toxigenic C. perfringens is insufficient to cause clinical disease [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. A critical predisposing factor is concurrent coccidiosis caused by Eimeria species [<a href="#ref-5">5</a>]. Coccidial infection damages the intestinal epithelium, providing a protein-rich environment (including plasma proteins) that favors the proliferation of C. perfringens and facilitates its adherence to exposed collagen [<a href="#ref-5">5</a>, <a href="#ref-11">11</a>]. Dietary factors are also paramount. High-protein diets, particularly those rich in animal-derived proteins (e.g., fishmeal), and diets containing high levels of non-starch polysaccharides (NSPs) like wheat, barley, or rye, increase digesta viscosity and provide substrates for clostridial growth [<a href="#ref-4">4</a>]. Stressors such as high stocking density, poor litter management, feed withdrawal, and mycotoxins can further compromise intestinal integrity and immune function, predisposing birds to NE [<a href="#ref-4">4</a>, <a href="#ref-13">13</a>].

Epidemiology

The epidemiology of NE has been profoundly shaped by the global trend toward the removal of antibiotic growth promoters (AGPs) from poultry feed [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-14">14</a>]. For decades, AGPs were used at sub-therapeutic levels to suppress C. perfringens and other pathogens, effectively controlling NE [<a href="#ref-2">2</a>]. Following the ban of AGPs in many regions, including the European Union, Canada, and Hong Kong, the incidence of both clinical and subclinical NE has increased substantially [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. The disease is most commonly observed in broiler chickens between 2 and 6 weeks of age, coinciding with the peak period of growth and the waning of maternal immunity [<a href="#ref-4">4</a>]. While chickens are the primary host, NE has also been experimentally reproduced in turkeys, demonstrating that the disease can affect other poultry species. The prevalence of specific C. perfringens strains and their antimicrobial resistance profiles vary geographically, with tetracycline resistance genes (e.g., tet) being the most frequently detected [<a href="#ref-8">8</a>].

Clinical Signs

Clinical signs of NE vary depending on the form of the disease. In the acute form, birds may be found dead without premonitory signs due to rapid toxemia [<a href="#ref-17">17</a>]. Morbidity and mortality can be high, with mortality rates reaching 50% in untreated flocks [<a href="#ref-4">4</a>]. Affected birds appear depressed, with ruffled feathers, drooping wings, and closed eyes [<a href="#ref-17">17</a>]. Diarrhea is a common sign, with feces often being watery, dark, or containing undigested feed [<a href="#ref-17">17</a>]. In the subclinical form, the only observable signs are a reduction in growth rate, poor feed conversion, and flock unevenness [<a href="#ref-2">2</a>, <a href="#ref-16">16</a>]. This form is often undetected until processing, where reduced carcass weight and increased condemnations become apparent [<a href="#ref-2">2</a>].

Pathology

Gross Lesions

The hallmark gross lesion of NE is a friable, distended small intestine, particularly the jejunum and ileum [<a href="#ref-17">17</a>]. The intestinal wall is often thin and dilated, and the mucosal surface is covered by a characteristic "Turkish towel" or "carpet-like" pseudomembrane composed of necrotic debris, fibrin, and inflammatory cells [<a href="#ref-17">17</a>]. The intestinal lumen may contain a dark, bloody fluid [<a href="#ref-17">17</a>]. In severe cases, the necrosis can extend into the deeper layers of the intestinal wall.

Histopathology

Histologically, NE is characterized by massive coagulative necrosis of the villi, with the tips of the villi being most severely affected [<a href="#ref-6">6</a>, <a href="#ref-17">17</a>]. The lamina propria is infiltrated by heterophils and mononuclear cells [<a href="#ref-6">6</a>]. Large numbers of large, Gram-positive, rod-shaped bacteria (C. perfringens) are often observed adhering to the necrotic mucosal surface [<a href="#ref-6">6</a>, <a href="#ref-17">17</a>]. The lesions are typically sharply demarcated from adjacent normal tissue [<a href="#ref-17">17</a>].

Diagnosis

Diagnosis of NE is based on a combination of clinical signs, gross pathology, histopathology, and laboratory confirmation of C. perfringens and its toxins.

Clinical and Pathological Diagnosis

A presumptive diagnosis can be made based on the characteristic gross lesions observed at necropsy, particularly the pseudomembrane in the small intestine [<a href="#ref-17">17</a>]. Histopathological examination of intestinal sections confirms the diagnosis by demonstrating coagulative necrosis and the presence of large Gram-positive rods [<a href="#ref-6">6</a>, <a href="#ref-17">17</a>].

Microbiological and Molecular Diagnostics

Isolation of C. perfringens from intestinal contents or lesions on selective media (e.g., tryptose-sulfite-cycloserine agar) under anaerobic conditions is a standard confirmatory step [<a href="#ref-6">6</a>]. However, because C. perfringens is a normal inhabitant of the gut, quantitative culture is important; high numbers (e.g., >10^7 CFU/g) are suggestive of NE [<a href="#ref-7">7</a>]. Molecular methods, such as polymerase chain reaction (PCR), are used for toxinotyping and detecting virulence genes, including netB, cpa, and pilus genes [<a href="#ref-8">8</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>]. Whole-genome sequencing (WGS) provides a comprehensive view of the genetic makeup of isolates, including antimicrobial resistance genes and virulence factors [<a href="#ref-8">8</a>].

Immunological and Rapid Diagnostic Tests

Rapid diagnostic tests have been developed for field use. One such test is a protein A agglutination assay that detects C. perfringens alpha-toxin in fecal samples [<a href="#ref-20">20</a>]. This test uses IgG antibodies against alpha-toxin conjugated to Staphylococcus aureus cells containing protein A, providing a rapid, specific, and sensitive detection method with a lower detection limit of 12 ng/mL of toxin [<a href="#ref-20">20</a>]. Commercial ELISA kits are also available for the detection of NetB toxin or antibodies against it.

Differential Diagnosis

NE must be differentiated from other enteric diseases that cause similar lesions. These include coccidiosis, which often precedes NE, and other bacterial infections such as ulcerative enteritis caused by Clostridium colinum and salmonellosis [<a href="#ref-5">5</a>]. Non-Clostridium perfringens infectious agents can also produce NE-like lesions and must be considered in the differential diagnosis.

flowchart TD
 A["Suspected Necrotic Enteritis<br>Clinical Signs + Mortality"] --> B{"Post-Mortem Examination"}
 B --> C["Gross Lesions: Pseudomembrane,<br>Friable Intestine"]
 C --> D["Histopathology: Coagulative Necrosis,<br>Gram-Positive Rods"]
 D --> E["Laboratory Confirmation"]
 E --> F["Microbiological Culture<br>Anaerobic, Selective Media"]
 E --> G["Molecular Diagnostics<br>PCR for netB, cpa, pilus genes"]
 E --> H["Rapid Immunological Test<br>e.g., Alpha-toxin Agglutination"]
 F & G & H --> I["Confirm NE Diagnosis"]
 I --> J["Implement Management & Control"]

Treatment

Antimicrobial Therapy

Historically, treatment of NE relied on the use of in-feed or water-soluble antibiotics, such as bacitracin, lincomycin, and tylosin [<a href="#ref-6">6</a>, <a href="#ref-21">21</a>]. However, the emergence of antimicrobial resistance and the ban on AGPs have limited these options [<a href="#ref-1">1</a>, <a href="#ref-8">8</a>]. Antibiotic sensitivity testing of isolates is recommended to guide therapy where antibiotics are still permitted [<a href="#ref-6">6</a>]. The presence of resistance genes, such as erm(T) for macrolide resistance, underscores the need for judicious antibiotic use [<a href="#ref-8">8</a>].

Non-Antibiotic Alternatives

The search for effective non-antibiotic alternatives has intensified. Several strategies have shown promise:

  • Probiotics: Lactobacillus-based probiotics are among the most studied alternatives [<a href="#ref-1">1</a>, <a href="#ref-16">16</a>]. They work by competing with C. perfringens for adhesion sites and nutrients, producing antimicrobial substances, and modulating the host immune response to reduce inflammation [<a href="#ref-1">1</a>]. Probiotics have been shown to improve weight gain, FCR, and reduce mortality in NE-challenged birds [<a href="#ref-1">1</a>, <a href="#ref-16">16</a>].
  • Prebiotics, Organic Acids, and Essential Oils: These feed additives can modify the gut microbiota, lower intestinal pH, and directly inhibit C. perfringens [<a href="#ref-2">2</a>, <a href="#ref-14">14</a>]. Plant extracts, particularly those containing tannins and essential oils, have demonstrated antimicrobial activity against C. perfringens and coccidia both in vitro and in vivo [<a href="#ref-14">14</a>].
  • Bacteriophages: Phage therapy offers a targeted approach. A rationally designed phage cocktail, based on cross-resistance profiles, has been shown to significantly improve survival, reduce intestinal lesions, and suppress C. perfringens colonization in NE-challenged chickens [<a href="#ref-3">3</a>].
  • Natural Adsorbents: Materials such as biochar and clay minerals have been proposed for their ability to bind toxins (e.g., NetB) and modulate the gut environment, though direct evidence for NetB-specific adsorption is currently lacking [<a href="#ref-22">22</a>].
  • Microelements: Prolonged-release formulations of microelements can modify the intestinal microenvironment, affecting the life cycle of enteropathogens and stabilizing the microbiome [<a href="#ref-23">23</a>].

Control and Management

Vaccination

Vaccination is considered the most effective long-term strategy for controlling NE [<a href="#ref-10">10</a>, <a href="#ref-24">24</a>]. The goal is to induce protective immunity against key virulence factors, primarily NetB and CPA [<a href="#ref-10">10</a>]. Currently, only a few commercial vaccines are available, and they offer partial protection [<a href="#ref-10">10</a>]. Research is focused on developing more effective vaccines using multiple antigens (e.g., NetB, CPA, FBA, ZMP, pilus proteins like CnaA and FimA) and novel delivery systems, including in ovo and oral routes [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>]. Bivalent vaccines targeting both NE and other diseases, such as avian colibacillosis, are also under development [<a href="#ref-25">25</a>]. Novel adjuvants, such as a Protein A-IgG matrix complex, are being evaluated to enhance vaccine efficacy [<a href="#ref-26">26</a>]. Live vectored vaccines expressing alpha-toxin have also been explored.

Management and Biosecurity

Effective management is crucial for preventing NE, especially in the absence of AGPs [<a href="#ref-4">4</a>, <a href="#ref-13">13</a>]. Key management strategies include:

  • Coccidiosis Control: Implementing effective coccidiosis vaccination or control programs is critical, as coccidiosis is a major predisposing factor [<a href="#ref-5">5</a>].
  • Nutritional Management: Formulating diets with lower levels of animal protein and using feed enzymes (e.g., xylanases) to reduce digesta viscosity can limit substrate availability for C. perfringens [<a href="#ref-4">4</a>, <a href="#ref-27">27</a>].
  • Litter Management: Maintaining dry, clean litter reduces environmental contamination and stress on the birds [<a href="#ref-4">4</a>].
  • Stocking Density: Avoiding overstocking minimizes stress and the fecal-oral transmission of pathogens [<a href="#ref-4">4</a>].
  • Biosecurity: Strict biosecurity protocols help prevent the introduction of virulent C. perfringens strains and other pathogens [<a href="#ref-4">4</a>].

Experimental Models

The development and refinement of experimental models are essential for testing new interventions [<a href="#ref-15">15</a>]. Models typically involve a combination of predisposing factors (e.g., coccidial challenge, high-protein diet) followed by oral challenge with a virulent C. perfringens strain [<a href="#ref-15">15</a>]. A subclinical NE model based on natural C. perfringens uptake from the barn environment has also been developed to better mimic field conditions.

Conclusion

Necrotic enteritis remains a major challenge for the global poultry industry, driven by the complex interplay between C. perfringens virulence factors, host susceptibility, and environmental triggers. The post-antibiotic era has necessitated a paradigm shift toward integrated control strategies that combine vaccination, nutritional management, biosecurity, and the use of non-antibiotic alternatives such as probiotics, bacteriophages, and plant extracts. Continued research into the molecular pathogenesis of NE, including the role of the pilus and quorum sensing, will be critical for the development of next-generation vaccines and therapeutics.

Related Clinical & Scientific Guides

References

[1] Razzaq, S., Hina, Q., Muneeb, M., et al. A Narrative Review on The Beneficial Effects of Lactobacillus Probiotics Against [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Bio Communications*. 2025. [Link](https://www.semanticscholar.org/paper/72085902eb940f344beab7b5fa1b8ccaf6bc9e09) [2] Emami, N., Dalloul, R. Centennial Review: Recent developments in host-pathogen interactions during [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-bacterial). *Poultry Science*. 2021. [Link](https://www.semanticscholar.org/paper/f368b7047f101b5a2779300c39165c9a1840eb8f) [3] Ahn, E., Kim, J., Tobin, I., et al. Cross-resistance-guided phage cocktail design for effective mitigation of [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-pathogenesis-control). *Microbiology Research*. 2026. [Link](https://www.semanticscholar.org/paper/9c7937dc7f39c15dcdc1735b86bd8c01a7aa05c4) [4] Akram, W., Kaleem, M., Hamza, M., et al. Effect of Management in controlling [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry). *International Journal of Multidisciplinary Sciences and Arts*. 2022. [Link](https://www.semanticscholar.org/paper/55868b41ba0ad78612fa244918ac3f15c4dec1ee) [5] Wiedosari, E., Sani, Y. Coccidiosis as A Predisposition Factor for [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry) and Their Prevention. *Journal*. 2020. [Link](https://www.semanticscholar.org/paper/56f08ed4a66b3d996a6ae0fcc0240c6ae82cce19) [6] Shelke, P., Pawade, M., Mhase, P., et al. Antibiotic Sensitivity and Histopathological Study of Clostridium perfringens Associated with [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *International Journal of Current Microbiology and Applied Sciences*. 2018. [Link](https://www.semanticscholar.org/paper/6ac406c64786aba9ade84d4c70f2190769070363) [7] Johansson, A. Clostridium perfringens the causal agent of [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-bacterial). *Journal*. 2006. [Link](https://www.semanticscholar.org/paper/67aa5b88ea147013a822422973f92932d005cd2b) [8] García-Vela, S., Martínez-Sancho, A., Ben Said, L., et al. Pathogenicity and Antibiotic Resistance Diversity in Clostridium perfringens Isolates from Poultry Affected by [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) in Canada. *Pathogens*. 2023. [Link](https://www.semanticscholar.org/paper/cc3e938217970d39b0c6872afd6f6fa6fdd6367b) [9] Flores-Díaz, M., Barquero-Calvo, E., Ramírez, M., et al. Role of Clostridium perfringens Toxins in [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-pathogenesis-control). *Journal*. 2016. [Link](https://www.semanticscholar.org/paper/8e301b0a75e38042879568fda0b9b55e371d95c1) [10] Waller, S., Galvão, C. C., Rodrigues, R. R., et al. Clostridium perfringens Antigens and Challenges for Development of Vaccines against [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry). *Anaerobe*. 2024. [Link](https://www.semanticscholar.org/paper/2938c251b3e53adbb5b4ad2314e962fac2a774b6) [11] Lepp, D., Zhou, Y., Ojha, S., et al. Clostridium perfringens Produces an Adhesive Pilus Required for the Pathogenesis of [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Journal of Bacteriology*. 2021. [Link](https://www.semanticscholar.org/paper/e33ec1efc7cf14ae9116ff474bea23d73b6f8447) [12] Yu, Q., Lepp, D., Mehdizadeh Gohari, I., et al. The Agr-Like Quorum Sensing System Is Required for Pathogenesis of [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) Caused by Clostridium perfringens in Poultry. *Infection and Immunity*. 2017. [Link](https://www.semanticscholar.org/paper/272ba95029684256f7c87adf904149b0dae1c814) [13] Tsiouris, V. Poultry management: a useful tool for the control of [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Avian Pathology*. 2016. [Link](https://www.semanticscholar.org/paper/4107cc0cafb70a244cc404b9b4072718f3455ebb) [14] Carrasco, J. D., Redondo, L., Redondo, E., et al. Use of Plant Extracts as an Effective Manner to Control Clostridium perfringens Induced [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-bacterial). *BioMed Research International*. 2016. [Link](https://www.semanticscholar.org/paper/3ac011109f0831b8f3f50f92c97c3f47e2dd7d08) [15] Dias, G. S., Chagas, K. P. F., Silva, A. C., et al. Experimental induction of subclinical [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-pathogenesis-control) - a review. *Revista Agraria Academica*. 2026. [Link](https://www.semanticscholar.org/paper/9f7bcc3411efb2b1a4bc157ec83753fe22701c8b) [16] Khalique, A., Zeng, D., Shoaib, M., et al. Probiotics mitigating subclinical [necrotic enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) (SNE) as potential alternatives to antibiotics in poultry. *AMB Express*. 2020. [Link](https://www.semanticscholar.org/paper/fce07da94f0c545567b523847f19cc15758c7dea) [17] Malmarugan, S., Sivaseelan, S., Rajeswar, J. Pathology of [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry). *Journal*. 2013. [Link](https://www.semanticscholar.org/paper/e06f3e417339c1039c15ff1b12a2fdc3b608dcbb) [18] Shelke, P. Molecular Profiling of Clostridium perfringens Associated with [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Journal*. 2018. [Link](https://www.semanticscholar.org/paper/87d937d5a440e66ab8c1d85634a9ba6bfa78bd79) [19] Shelke, P. Toxinotyping of Clostridium perfringens in Poultry from [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) Cases. *Journal of Animal Research*. 2020. [Link](https://www.semanticscholar.org/paper/47f7abd0710f675290867515357af93da08a9373) [20] Kurnia, R., Nugroho, C. M. H., Silaen, O. S. M., et al. Development of Rapid Detection Kit for [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) Disease in Poultry using Protein A Agglutination. *World's Veterinary Journal*. 2024. [Link](https://www.semanticscholar.org/paper/9df77159db5a9fa02d3329448482a762e33ef47f) [21] Mahmood, K., Rahman, S., Hussain, I., et al. Non-antibiotic strategies for the control of [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Journal*. 2014. [Link](https://www.semanticscholar.org/paper/ea724bad8e493cd7fb684bd1dcc1e17a61683f67) [22] Agada, S. E., Oladokun, S. Natural Adsorbents as Therapeutic Candidates Against [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-bacterial): A Conceptual Review. *Agriculture*. 2026. [Link](https://www.semanticscholar.org/paper/bebfef0ab070f041386b5b9c8cb33e5f5741185a) [23] Stybel, V., Mazur, I. MICROELEMENTS WITH PROLONGED RELEASE TECHNOLOGY AS A STRATEGY FOR CONTROL OF COCCIDIOSIS AND [NECROTIC ENTERITIS](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) IN INDUSTRIAL POULTRY FARMING. *Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology*. 2026. [Link](https://www.semanticscholar.org/paper/d31c633d310e9ac9bab6e27fd2222f7cbc3138cb) [24] Gaucher, M.-L. Unravelling [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-pathogenesis-control): The Quest for an Effective Vaccine. *Scientia*. 2025. [Link](https://www.semanticscholar.org/paper/e54563d1ef023c4b4d5fa036f0e253af9a7eb7be) [25] Indrawati, A., Safika, S., Nugroho, C., et al. Development and Evaluation of a Bivalent Oil-Adjuvanted Vaccine Against [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) and Avian [Colibacillosis in Poultry](/knowledge/bacteria/avian-bacteria/colibacillosis-in-poultry-escherichia-coli-infections-in-chickens). *Advances in Animal and Veterinary Sciences*. 2025. [Link](https://www.semanticscholar.org/paper/ae70af3a78c87f31edd8e066da29ef06de35015f) [26] Rahmi, V. A., Indrawati, A., Poetri, O., et al. Evaluation of a Novel Protein A (Staphylococcus aureus), IgG Matrix Complex as an Adjuvant for a [Poultry Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) Toxoid Vaccine. *Advances in Animal and Veterinary Sciences*. 2025. [Link](https://www.semanticscholar.org/paper/288dc87689b66bf827a3b596b8f918d443e4d5c0) [27] Naeem, M. Combating [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) through nutritional interventions: a review of alternatives to antibiotics. *Animal Diseases*. 2026. [Link](https://www.semanticscholar.org/paper/da2e2e57db8847ad4222d4c120f27af96d65ed91) [28] Potential effects of herbal tea extracts as an alternative to antimicrobials to control the [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Asian Journal of Agriculture and Biology*. 2025. [Link](https://www.semanticscholar.org/paper/b1f1cec3d36598bb4c0bc96f3dcf98aa6a72ec1c) [29] Lee, K.-W. Recent development on controlling [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry). *Animal Industry and Technology*. 2024. [Link](https://www.semanticscholar.org/paper/5fa8658c5d794b391d68c0c50e74045e60acbb34) [30] Abid, S., Azeem, T., Chaudhary, Z. I., et al. THREAT OF [NECROTIC ENTERITIS IN POULTRY](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-bacterial) AND ITS CONTROL WITHOUT USE OF ANTIBIOTICS: A REVIEW. *Journal*. 2016. [Link](https://www.semanticscholar.org/paper/2d68a68fb757f2ae3434366f2b427ba0782bb0b9) [31] Piva, A. [Necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry-pathogenesis-control). *Journal*. 2015. [Link](https://www.semanticscholar.org/paper/17806ff77f32b992cdd7e00119937477595d8b03)